TANG KEVIN (CIK 1178579) reported 28 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-08). Recent activity: Buy BOLD (27,062 shares), Buy BOLD (15,810 shares), Buy BOLD (14,338 shares), Buy BOLD (25,930 shares), Buy BOLD (100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 27,062 | $67,384 |
| 2026-07-08 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 15,810 | $39,209 |
| 2026-07-08 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 14,338 | $35,271 |
| 2026-07-02 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 25,930 | $65,862 |
| 2026-07-02 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 100 | $250 |
| 2026-07-02 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 71,612 | $178,314 |
| 2026-07-02 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 9,821 | $24,454 |
| 2026-06-02 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 2,299 | $35,290 |
| 2026-06-02 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 262,682 | $4.0M |
| 2026-06-02 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 343,521 | $5.2M |
| 2026-06-02 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 99 | $1,519 |
| 2026-06-02 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer | Buy | 206,005 | $3.1M |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 300,000 | $4.2M |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 214,839 | $3.0M |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 1,600 | $23,008 |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 83,561 | $1.2M |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 115,792 | $1.6M |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 184,208 | $2.6M |
| 2025-08-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 1.0M | $10.1M |
| 2025-08-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 100,000 | $1.1M |
| 2025-08-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 200,000 | $2.3M |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 399,280 | $3.1M |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 100,720 | $802,738 |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 351,962 | $2.8M |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Director | Buy | 148,038 | $1.2M |
Source: SEC Form 4 filings · as of 2026-07-08